Priser
Platform
Blog
Om os
Download
4016
Middle East Pharmaceutical
SAUDI STOCK EXCHANGE
0

Om

Middle East Pharmaceutical Company Ltd. is a prominent entity in the pharmaceuticals sector, primarily involved in the manufacture and distribution of a wide range of healthcare products. Focused on addressing local and regional healthcare needs, the company delivers medicinal products that serve therapeutic areas such as cardiology, endocrinology, and oncology, among others. The company's operations are integral to the healthcare infrastructure in the Middle East, supporting both retail and institutional clients, including hospitals and clinics. By coupling rigorous research and development with strict adherence to regulatory standards, Middle East Pharmaceutical Company Ltd. ensures the availability of quality medicines. Its strategic presence in the Middle East medical market underscores its role in enhancing access to essential medicines and supporting public health initiatives.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MIDDLE EAST PHARMACEUTICAL MED ENDAVU: Køb Middle East Pharmaceutical ($4016) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Middle East Pharmaceutical, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker4016
Land
Saudi-Arabien
Antal medarbejdere731
Hjemmesideavalonpharmaceutical.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

2,35SAR
'25
1,32SAR
'26
Ex-udbytte-dato30. mar. 2026
Udbytteafkast2,33%